Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Encoded closes $275M Series F for Dravet syndrome drug

Encoded Therapeutics has tacked on $275 million in new capital, closing a Series F round led by GV and an undisclosed healthcare investor. The precision genetic medicine biotech said Wednesday that ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Wednesday 9 September →